After last year’s high viral season with RSV, COVID-19 and flu straining hospital capacity, the FDA has approved four RSV vaccines — two for adults 60 and older, one for toddlers and another for pregnant people to protect newborns.
Every year, between 6,100 and 10,300 people die after contracting RSV, according to the CDC. The new approvals offered a hope of lessening the burden, but insurance companies might be getting in the way.
Medicare Part D covers the vaccine, but Medicare Part B doesn’t, according to the Times. Some private payers aren’t covering the shot, including Anthem Blue Cross Blue Shield, and older adults told the Times they left their pharmacy appointments without the vaccine because of the cost.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
